A recent executive order focuses on measures to prevent the progression of end-stage kidney disease. This is exciting news for patients and health care providers, but it will be important to monitor the costs and quality of care as well as the commitment of policymakers. Continue Reading
The abrupt and dramatic reduction of advisory bodies mandated by the Trump administration threatens the vitality of our nation’s science and technology enterprise. Continue Reading
Here is a short summary of what vaccines are and how they work, drawn from evidence-based medical research articles. Continue Reading
The author and his collaborators at McGill University investigate the effect of Peru’s cash transfer program, Juntos, on the contraceptive and family planning decisions of low-income participants.
Continue Reading
A blog by student intern Kathryn Kundrod notes that while a right-to-try bill did not get far in Texas’ 2019 legislative session, it reflected efforts to further expand RTT in the state. Continue Reading
There is no doubt that the status quo in health care is unacceptable, and that we should introduce policies that make health care affordable and accessible to more Americans. But the fascination with Medicare-for-All is impractical, and it distracts us from finding solutions that are economically feasible and beneficial to individuals in need. Continue Reading
While the U.S. still maintains the overall lead in Nobel prizes (with the exception of literature), the rate at which American scientists have been awarded the prize has declined since the late 1970s. Continue Reading